News
Philanthropist Tej Kohli pledges $2 million on biotech solutions for eliminating corneal blindness by 2030
Tej Kohli believes that biotechnology will offer solutions to some of the world’s greatest humanitarian challenges. $2 million gift to Massachusetts Ear and Eye to establish ‘The Tej Kohli Cornea Program’.
Mylan and Pfizer’s Upjohnto combine and create a new biosimilar business
The new company will transform and accelerate each businesses’ ability to serve patients’ needs and expand their capabilities across more than 165 markets by bringing together 2 two highly complementary businesses.
DBT seeks comments/suggestions on Draft National Guidelines for Gene Therapy product development,clinical trials
The draft document is being placed in public domain for comments/suggestions from the concerned stakeholders (scientists, academics, industries working in the field).
Health Ministry develops National Strategic Plan with a goal to end TB by 2025
The Minister of State for Health and Family Welfare, Ashwini Kumar Choubey has stated in a written reply in the Lok Sabha recently about the status of tuberculosis in India and a revised action plan to contain TB.
Alvotech and Cipla Gulf partner to commercialize key biosimilar products in select markets
Under the partnership, Alvotech will be responsible for development and supply of the product, while Cipla Gulf will be responsible for registration and commercialization.
Exhibit in the 'India Pavilion' at BIO 2026
